GSA Capital Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,469
| Closed | -$342K | – | 1967 |
|
|
2025
Q1 | $342K | Buy |
+1,469
| New | +$356K | 0.03% | 1055 |
|
|
2024
Q2 | – | Sell |
-1,844
| Closed | -$403K | – | 1868 |
|
|
2024
Q1 | $403K | Buy |
+1,844
| New | +$406K | 0.03% | 1035 |
|
|
2022
Q4 | – | Sell |
-3,407
| Closed | -$599K | – | 1698 |
|
|
2022
Q3 | $599K | Buy |
3,407
+1,786
| +110% | +$366K | 0.08% | 443 |
|
|
2022
Q2 | $326K | Buy |
1,621
+465
| +40% | +$99.1K | 0.05% | 772 |
|
|
2022
Q1 | $262K | Sell |
1,156
-178
| -13% | -$41.9K | 0.04% | 996 |
|
|
2021
Q4 | $360K | Buy |
1,334
+68
| +5% | +$16.8K | 0.05% | 809 |
|
|
2021
Q3 | $306K | Buy |
+1,266
| New | +$319K | 0.03% | 1006 |
|
|
2020
Q1 | – | Sell |
-4,703
| Closed | -$683K | – | 1323 |
|
|
2019
Q4 | $683K | Sell |
4,703
-1,671
| -26% | -$241K | 0.08% | 445 |
|
|
2019
Q3 | $920K | Sell |
6,374
-1,848
| -22% | -$270K | 0.12% | 198 |
|
|
2019
Q2 | $1.22M | Buy |
+8,222
| New | +$1.15M | 0.14% | 163 |
|
|
2019
Q1 | – | Sell |
-4,964
| Closed | -$539K | – | 1567 |
|
|
2018
Q4 | $539K | Sell |
4,964
-20,897
| -81% | -$2.8M | 0.06% | 519 |
|
|
2018
Q3 | $3.86M | Buy |
+25,861
| New | +$3.93M | 0.21% | 42 |
|
|
2018
Q2 | – | Sell |
-4,005
| Closed | -$557K | – | 1818 |
|
|
2018
Q1 | $557K | Buy |
4,005
+1,017
| +34% | +$149K | 0.03% | 1008 |
|
|
2017
Q4 | $409K | Sell |
2,988
-2,957
| -50% | -$391K | 0.02% | 1046 |
|
|
2017
Q3 | $771K | Buy |
+5,945
| New | +$793K | 0.05% | 683 |
|
|
2017
Q2 | – | Sell |
-5,954
| Closed | -$734K | – | 1818 |
|
|
2017
Q1 | $734K | Buy |
5,954
+2,690
| +82% | +$319K | 0.04% | 845 |
|
|
2016
Q4 | $360K | Buy |
+3,264
| New | +$363K | 0.02% | 1216 |
|
|
2016
Q3 | – | Sell |
-8,736
| Closed | -$978K | – | 1864 |
|
|
2016
Q2 | $978K | Buy |
+8,736
| New | +$940K | 0.05% | 639 |
|
|
2016
Q1 | – | Sell |
-2,930
| Closed | -$311K | – | 1805 |
|
|
2015
Q4 | $311K | Sell |
2,930
-3,848
| -57% | -$397K | 0.02% | 1442 |
|
|
2015
Q3 | $632K | Sell |
6,778
-10,300
| -60% | -$1.07M | 0.03% | 974 |
|
|
2015
Q2 | $1.78M | Sell |
17,078
-12,421
| -42% | -$1.29M | 0.07% | 460 |
|
|
2015
Q1 | $3.19M | Buy |
+29,499
| New | +$3.03M | 0.13% | 134 |
|
|
2014
Q4 | – | Sell |
-19,474
| Closed | -$1.7M | – | 1810 |
|
|
2014
Q3 | $1.7M | Sell |
19,474
-7,762
| -28% | -$701K | 0.09% | 243 |
|
|
2014
Q2 | $2.4M | Buy |
27,236
+15,289
| +128% | +$1.32M | 0.11% | 191 |
|
|
2014
Q1 | $1.01M | Buy |
+11,947
| New | +$953K | 0.07% | 329 |
|
Other funds holding LH
GSA Capital Partners's LH Position: Q2 2025 in Review
GSA Capital Partners sold out of Labcorp (LH) in Q2 2025, closing a stake of 1,469 shares — an estimated $342K sold.
GSA Capital Partners first reported a position in LH in Q1 2014 and held it in 25 quarters. The position peaked at $3.86M in Q3 2018. 975 funds tracked by Wall St. Rank hold LH as of Q2 2025.
- GSA Capital Partners reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
- GSA Capital Partners sold 1,469 Labcorp shares in Q2 2025, an estimated $342K.
- GSA Capital Partners first reported a position in Labcorp in Q1 2014 and held it in 25 quarters.
- GSA Capital Partners's Labcorp position peaked at $3.86M in Q3 2018.
- 975 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.
Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.